Kabra Drugs announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 26 December 2025.Powered by Capital Market - Live News

Kabra Drugs will hold a meeting of the Board of Directors of the Company on 28 November 2025.Powered by Capital Market - Live News

Net profit of Kabra Drugs reported to Rs 1.84 crore in the quarter ended September 2025 as against net loss of Rs 0.40 crore during the previous quarter ended September 2024. Sales reported to Rs 19.76 crore in the quarter ended September 2025. There were no Sales reported during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales19.760 0 OPM %10.320 - PBDT2.22-0.40 LP PBT2.21-0.40 LP NP1.84-0.40 LP Powered by Capital Market - Live News

Kabra Drugs will hold a meeting of the Board of Directors of the Company on 13 November 2025.Powered by Capital Market - Live News

Kabra Drugs will hold a meeting of the Board of Directors of the Company on 8 October 2025.Powered by Capital Market - Live News